mutual funds workshop health and technology: high-powered
TRANSCRIPT
AAII Journal/November 1998 3
MUTUAL FUNDS WORKSHOP
As the stock market gives up ground, which it inevitably will do from timeto time, investors often think about what they missed in the last run-up andhow to position their portfolios for the equally inevitable next run-up. Just asinvestors might increase their cash positions in anticipation of a marketdecline or move from more aggressive stock holdings to less volatile stocks, inanticipation of the next great market surge investor’s thoughts often turn tothe stocks and sectors with the greatest promise.
What might first come to mind? Health and technology—health because ofthe aging population, gene research, new pharmaceuticals and drugs, and thepromise of biotech in general; technology because, whatever technology is, itis synonymous with growth.
Given the complexities of firms in these areas, sector funds in health andtechnology provide both specialized management and necessary diversificationfor investors interested in these sectors. It is often suggested, for example,when investing in biotech stocks that investing in one biotech stock is poten-tially disastrous, while a portfolio of biotech stocks is simply high risk. Fewinvestors have the depth of knowledge or the experience in the health sciencesto assemble a portfolio of 10 to 15 individual stocks in biotech, drugs andpharmaceuticals, and medical services and equipment. And the same is truefor technology.
While building a mutual fund portfolio made up solely of a few volatilesector funds is far from optimal for just about any individual investor, addinga few sector funds to an already diversified portfolio to boost the portfolioweightings in industries with exceptional long-term growth potential is areasonable approach for many. The difficulty for investors beyond the deci-sion on the degree of portfolio commitment to any sector is deciphering justwhat specific sectors are in a health sector fund or a technology sector fund.
Table 1 lists the no-load and low-load sector funds reported in The Indi-vidual Investor’s Guide to Low-Load Mutual Funds and the Quarterly Low-Load Mutual Fund Update that are health and technology related.
While the health sector funds run the gamut from biotechnology to medicalservices delivery, they all arguably fall within the health classification. Whereto draw the line on technology sector funds, however, is problematic. Aretelecommunication firms providers of technology, enhancers of technology orusers of technology? MCI and Worldcom, for instance, are in the telecommu-nication services industry, which is high tech, of course, but are they technol-ogy stocks? Probably not, but close. Two telecommunications sector funds,Fidelity Select Developing Communications and Fidelity Select Telecommuni-cations are included under technology in Table 1 for comparison, but reason-able arguments can be made that they are not truly technology funds. Inves-tors must make the final cut after reviewing their existing portfolio to deter-mine how any sector fund might create overlaps with existing holdings or failto fill in portfolio sector gaps.
HEALTH
First, a look at the health sector funds. Listed are the top three sectors for
By John Markese
Given thecomplexities ofcompanies in thehealth andtechnology fields,funds focusing onthese sectors providespecializedmanagement anddiversification forinvestors interestedin commitments inthese areas.
John Markese is president of AAII. The article was researched by Jean Henrich.
HEALTH AND TECHNOLOGY:HIGH-POWERED SECTOR FUNDS
4 AAII Journal/November 1998
MUTUAL FUNDS WORKSHOP
TABLE 1. HEALTH AND TECHNOLOGY SECTOR FUNDS
Health Sector Funds (Ticker)Health Sector Funds (Ticker)Health Sector Funds (Ticker)Health Sector Funds (Ticker)Health Sector Funds (Ticker) Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio)Top 3 Sectors (Percentage of Portfolio) Top 5 Stocks (PercentagTop 5 Stocks (PercentagTop 5 Stocks (PercentagTop 5 Stocks (PercentagTop 5 Stocks (Percentag
Fidelity Select Biotechnology (FBIOX) biotech 43%, drugs 17%, pharmac’l preparations 7% Genentech 10.4%, Chiron 6.
Merck 5.7%, Schering-Ploug
T. Rowe Price Health Sciences (PRHSX) pharmac’ls 25%, biotech 21%, hospital supply & med devices 16% Collagen 3.7%, IDX Systems
Warner-Lambert 2.7%, Nati
INVESCO Strategic Health Sciences (FHLSX) drugs 57%, medical equip 18%, biotech 5% Merck 7.2%, Bristol-Myers S
Schering-Plough 5.6%, Ame
Vanguard Specialized Health Care (VGHCX) drugs & pharmac’ls 51%, international 21%, Warner-Lambert 5.9%, Pfizer
medical & dental instruments & supplies 8.5% Bristol-Myers Squibb 4.8%,
Fidelity Select Health Care (FSPHX) drugs 42%, medical supplies & appliances 12%, hospitals 4% American Home Products 7.
Merck 5.9%, Bristol-Myers
Fidelity Select Medical Delivery (FSHCX) hospitals 35%, HMOs & outpatient care 24%, medical servs 6% United HealthCare 8.2%, He
HEALTHSOUTH 6.9%, Colu
Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)Technology Sector Funds (Ticker)
Fidelity Select Electronics (FSELX) semiconductors 29%, computers 23%, software & servs 13% Gateway 2000 6.0%, Hewlet
Microsoft 4.5%, ASM Lithog
T. Rowe Price Science & Technology (PRSCX) semiconductor 17%, commun’ns equip 14%, software 13% Parametric Technology 4.0%
Network Assoc. 3.4%, First
Fidelity Select Computers (FDCPX) computers 44%, semiconductors 16%, software & servs 11% Dell Computer 10.1%, EMC
Compaq Computer 4.1%, M
Fidelity Select Technology (FSPTX) software 16%, semiconductors 10%, microcomputers 5% Microsoft 9.7%, Selectron 4.
Micron Technology 2.7%, H
Fidelity Select Software & Comput Servs (FSCSX) software 54%, computer servs 10%, data process’g 6% Microsoft 11.2%, PeopleSoft
Siebel Systems 4.0%, Comp
Northern Technology (NTCHX) software & servs 36%, commun’ns equip 21%, Cisco Systems 4.7%, Lucent
electrical & electron compon 20% Dell Computer 4.4%, Yahoo
Robertson Stephens Information Age (RSIFX) software & servs 34%, semiconductors & compon 14%, Legato Systems 4.3%, Amer
commun’ns equip & servs 10% SAP AG 3.7%, Vitesse Sem
INVESCO Strategic Technology (FTCHX) software & servs 25%, computer hardware 13%, IBM 4.3%, Lexmark Int’l 3.2%
data process’g servs 10% CBT Group 2.8%, Ceridian 2
PBHG Technology & Communications (PBTCX) technology 63%, services 24%, health care 2% Ascend Comm 4.8%, J.D. Ed
Citrix Systems 4.0%, Comp
Fidelity Select Develop Commun (FSDCX) telephone equip 14%, telephone servs 12%, Cellstar 9.7%, Brightpoint 7.
wholesale electric appliances 10% Alcatel Alsthom 5.5%, Noki
Fidelity Select Telecommun (FSTCX) phone servs 47%, data commun equip 6%, WorldCom 8.6%, MCI Comm
TV & radio commun equip 5% AT&T 5.0%, Global Telesys
Source: Quarterly Low-Load Mutual Fund Update for statistics, with returns through Sept. 30, 1998; portfolio information supplied by the funds.
each fund with the percent of theportfolio by value invested in eachsector. In terms of the health carespectrum, Fidelity Select Biotechnol-ogy, with 43% in biotech, is at oneend, and Fidelity Select Medical
Delivery, with 35% of the portfolioinvested in the hospital category, isat the other end. These funds arelisted in rough order from thosecommitted significantly to biotech,through those that include drugs and
pharmaceuticals, medical devicesand, broader still, medical services.But funds report subsections andindustries differently, so sectorgrouping may be something differentfor each fund.
AAII Journal/November 1998 5
MUTUAL FUNDS WORKSHOP
e of Portfolio)e of Portfolio)e of Portfolio)e of Portfolio)e of Portfolio)
2%, Genzyme 5.8%, 62 162 1.49 3.00% front –1.0 11.5 10.6 16.7 –15.4 1.56
gh 4.4%
s 3.2%, Pfizer 2.7%, 77 133 1.35 none 0.5 na na 12.5 –15.4 na
onal Data 2.4%
Squibb 6.4%, Warner-Lambert 6.4%, 56 143 1.08 none 24.3 22.4 23.3 11.4 –10.5 1.26
erican Home Products 5.3%
r 5.2%, Pharmacia & Upjohn 5.1%, 99 10 0.40 1.00% 19.7 27.0 26.5 10.0 –10.5 0.96
, Abbott Laboratories 3.6% redemption fee
.9%, Warner-Lambert 7.6%, 62 59 1.33 3.00% front 29.3 27.1 29.7 11.6 –10.4 1.09
Squibb 4.9%, Schering-Plough 4.9%
alth Management Assoc. 8.0%, 49 109 1.57 3.00% front –17.0 6.3 14.6 12.0 –22.6 1.61
mbia/HCA Healthcare 5.7%, Tenet Healthcare 5.6%
t-Packard 5.9%, 104 435 1.18 3.00% front –25.6 11.2 25.4 17.4 –19.9 2.27
graphy 4.5%, Texas Instruments 3.3%
%, Analog Devices 3.5%, 51 125 0.97 none –15.5 4.4 15.6 14.9 –22.6 1.87
Data 3.3%, Maxim Integrated Products 3.2%
7.7%, Quantum 5.9%, 71 333 1.40 3.00% front 5.5 17.8 29.7 23.1 –14.0 2.29
Microsoft 4.1%
.2%, Dell Computer 4.0%, 108 556 1.38 3.00% front –4.2 11.9 20.2 17.5 –17.5 2.04
HBO & Co. 2.4%
t 7.5%, BMC Software 6.8%, 67 145 1.44 3.00% front 12.0 19.0 20.1 22.1 –18.3 1.96
puware 3.3%
t Technologies 4.5%, America Online 4.4%, 70 74 1.25 none 5.8 na na 18.0 –20.2 na
o 4.3%
rica Online 4.3%, Netword Assoc 3.7%, 46 369 1.82 none –16.0 na na 20.8 –24.4 na
miconductor 3.2%
%, Int’l Game Technology 3.2%, 120 237 1.05 none –9.3 12.5 16.0 10.9 –17.7 1.52
2.8%
dwards 4.6%; 64 259 1.30 none –19.7 21.6 na 17.3 –16.6 2.04
uware 3.9% Saville Systems 3.6%
.3%, Anicom 6.8%, 55 383 1.61 3.00% front –4.1 5.5 13.3 14.1 –20.3 1.96
a 4.3%
mun 7.5%, Tel-Save Holdings 6.6%, 31 157 1.51 3.00% front 7.1 12.5 13.4 14.2 –22.9 1.61
stems Group 3.6%
S&P 500 IndexS&P 500 IndexS&P 500 IndexS&P 500 IndexS&P 500 Index 9 .09 .09 .09 .09 .0 22 .522 .522 .522 .522 .5 19 .919 .919 .919 .919 .9 8 .08 .08 .08 .08 .0 –14.4–14.4–14.4–14.4–14.4 1 .121 .121 .121 .121 .12
S&P MidCap 400 IndexS&P MidCap 400 IndexS&P MidCap 400 IndexS&P MidCap 400 IndexS&P MidCap 400 Index –6.2–6.2–6.2–6.2–6.2 14 .114 .114 .114 .114 .1 13 .613 .613 .613 .613 .6 9 .99 .99 .99 .99 .9 18 .618 .618 .618 .618 .6 1 .321 .321 .321 .321 .32
Russell 2000 Small-Cap IndexRussell 2000 Small-Cap IndexRussell 2000 Small-Cap IndexRussell 2000 Small-Cap IndexRussell 2000 Small-Cap Index 19 .019 .019 .019 .019 .0 6 .86 .86 .86 .86 .8 9 .09 .09 .09 .09 .0 11 .111 .111 .111 .111 .1 –19.4–19.4–19.4–19.4–19.4 1 .421 .421 .421 .421 .42
Annual ReturnAnnual ReturnAnnual ReturnAnnual ReturnAnnual Return One-Month ReturnsOne-Month ReturnsOne-Month ReturnsOne-Month ReturnsOne-Month Returns (as of 9/30/98) (as of 9/30/98) (as of 9/30/98) (as of 9/30/98) (as of 9/30/98) Last Three YearsLast Three YearsLast Three YearsLast Three YearsLast Three Years TotalTotalTotalTotalTotal
No. ofNo. ofNo. ofNo. ofNo. of Portfol ioPortfol ioPortfol ioPortfol ioPortfol io ExpenseExpenseExpenseExpenseExpense MaximumMaximumMaximumMaximumMaximum One-One-One-One-One- Three-Three-Three-Three-Three- Five-Five-Five-Five-Five- High-High-High-High-High- Low-Low-Low-Low-Low- R iskR iskR iskR iskR iskStocksStocksStocksStocksStocks TurnoverTurnoverTurnoverTurnoverTurnover RatioRatioRatioRatioRatio LoadLoadLoadLoadLoad YearYearYearYearYear YearYearYearYearYear YearYearYearYearYear es tes tes tes tes t es tes tes tes tes t Index Index Index Index Index
(%) (%) (%) (%) (%) (%) (%) (%) (%) (%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%) (%)(%)(%)(%)(%)
As for individual stocks, Merck isthe most prevalent in the top fiveholdings, but all the major drug/pharmaceuticals makers are there:Warner-Lambert, Bristol-MyersSquibb, Schering-Plough, Pfizer,
Pharmacia & Upjohn, and AmericaHome Products. Fidelity SelectBiotechnology and T.Rowe PriceHealth Sciences tend to hold morebiotech drug companies—higher risk,higher return, drug development
stocks.How diversified are these sector
funds? A diversified sector fund issurely an oxymoron, but the under-lying question is: how concentratedis the portfolio? Fidelity Select
6 AAII Journal/November 1998
MUTUAL FUNDS WORKSHOP
Biotechnology, for example, holds62 stocks, but 43% of the portfoliois in biotech and 10.4% is in onestock, Genentech, while the top fivestocks make up 32.5% of theportfolio. Contrast this with T.RowePrice Health Sciences, which has 77stock holdings, 25% in pharmaceuti-cals as the top sector holding,Collagen as the top stock at 3.7%,and the top five stocks totaling only14.7% of the portfolio. Even amongsector funds, diversification is anissue that should be addressed. Themore concentrated the sectors, topstocks and number of total stocks,the more likely the fund is to havehigher risk.
Portfolio turnover ratios give someindication of how aggressive thesefunds transact. Portfolio turnover isthe lower of purchases or sales as apercentage of portfolio value on anannual basis. A 100% turnover,about the average for a stock fund,indicates a complete turnover of theportfolio by value, not necessarily achange in all stock holdings, how-ever. Vanguard Specialized HealthCare is barely actively managed,with a 10% turnover, while FidelitySelect Biotechnology at 162% isaggressively managed—two differentinvestment management styles.Beyond brokerage costs, which aresmall per share at institutional rates,there is still the cost of the bid-askspread, the difference between thebuy price and sell price, a quarterpoint (0.25%) or less for large liquidstocks but higher for less liquidsmaller stocks. Brokerage costs andspreads reduce fund returns. Themore turnover the greater thetransaction costs, brokerage fees,and spread for a fund.
The expense ratio is a measure ofportfolio return drag. Expressed as apercentage of the portfolio value, theexpense ratio includes all manage-ment fees and fund costs, including,if the fund assesses one, the annual12b-1 distribution (marketing)charge, but does not include broker-age costs and front-end loads, back-end loads, or redemption charges.
The average expense ratio foraggressive growth funds, how mostof these funds would be classified, is1.3%. Vanguard Specialized HealthCare, demonstrating its fund family’sphilosophy, has a very low 0.40%ratio. The only fund noticeablyhigher than the average is FidelitySelect Medical at 1.57%, althoughnot high enough to sound an alarm.Returns for mutual funds arereported net of expenses, so theexpense ratio in essence has alreadybeen subtracted from the perfor-mance figures.
For each of these health sectorfunds, one-year, three-year, and five-year annualized returns are reportedand for comparison the returns forthe Standard & Poor’s 500 index(large stock benchmark) and theStandard & Poor’s 400 (mid-sizedbenchmark) are given. Two riskmeasures are provided to judge thesefund’s returns. The first risk measureis simple: What is the best and worstone-month return over the last threeyears? The second risk measure is aratio of the return volatility of thefund to the average return volatilityof all mutual funds. A 1.00 ratiowould be equal to the average totalmutual fund risk, and a ratio of 2.00would be twice as volatile, forexample.
With the exception of VanguardSpecialized Health Care, and to alesser extent, Fidelity Select HealthCare, these are volatile sector funds.A drop of 10.0% in a month duringa period without a bear marketwould take the breath away frommany investors. But these funds alsohave the upside, 12% and even 16%in a month. As a group over the lastthree years, those funds invested inthe large drug stocks did the best,hospital/medical delivery probablythe worst and biotech somewhere inbetween, three patterns within onegrowth sector.
TECHNOLOGY FUNDS
Technology breaks down intothree primary subsections based
upon the holdings of these sectorfunds: semiconductors, software, andcomputer hardware. The technologysector funds are roughly listed in thisorder so that funds with relatedsector allocations are close by foreasier comparisons. Looking at thetop five holdings column, it is clearthat many holdings are Microsoftand the computer makers: Gateway2000, Dell, Compaq, and IBM. AndInternet stocks have a presence withAmerica Online, Yahoo and others.Remember that the two telecommu-nication sector funds, Fidelity SelectDeveloping Communications andFidelity Select Telecommunications,don’t really fit the category; they area stretch to call technology but arehere for comparisons and informa-tion.
As a group, technology sectorfunds are more spread out byindustry and stock holdings than thehealth sector, getting back to thequestion of just what is technology.For example, PBHG Technology andCommunications has 63% intechnology, however they definetechnology.
About a third of these funds holdmore than 100 stocks. INVESCOStrategic Technology holds 120stocks, far more than required to bediversified, and its top five stockholdings add up to only 16.3% ofthe portfolio.
Portfolio turnover ratios of someof these sector funds can be shock-ingly high; 556%, 435%, 383%.These are aggressive funds investingin high growth, high-risk stocks, andthe technology area has been inconstant evolution, reshaping itselfrapidly. And some of these expenseratios—Robertson Stephens Informa-tion Age at 1.82%, for example—are on the high side. As a group,technology funds have highertransaction costs and expenses,which are easily forgotten if theyperform well.
Some of these funds beat the S&P500, a tough benchmark to best,recently and over five years. But therisks were equally tough to beat.
AAII Journal/November 1998 7
MUTUAL FUNDS WORKSHOP
The two funds that far outdid theS&P 500 (19.9%) over five yearswere Fidelity Select Computers(29.7%) and Fidelity Select Elec-tronic (25.4%), but they had totalrisk ratios of 2.29 and 2.27 respec-tively, well more than twice the riskratio of the 1.12 for the S&P 500.And don’t overlook the monthextremes, a few up over 20.0% in amonth and those same ones downover 14.0% in another. That isvolatility that few funds everdisplay.
A SECTOR FUND CHECKLIST
Additions of health and technologyfunds are sure to alter a portfolio’scharacter with the promise of highreturns and the likelihood of occa-sional nose dives. Before you investin any sector fund, make sure youget an annual report and prospectusand check off these points:• What is the investment objective
of the fund (how does the fundcharacterize its sector)?
• What are the top three subsectors
and what percentage do theyrepresent of the portfolio?
• Do these subsector weightingsmatch the investment objective asyou understand it?
• What are the major stock holdings?• Does this fund fill in gaps in your
portfolio or is it overlapping?• How has this fund performed
against similar sector funds andagainst basic market benchmarks?
• How jarring have the performancepotholes hit by the fund been andcan you stand the ride? ✦✦✦✦✦
www.aaii.com
Recent New Features for Members Only
Take a Refresher CourseSit in on investing mini-courses by following our InvestingPathways, found at the bottom right-hand column of ourhome page. Each month, a new Pathway begins, with adifferent stepping-stone added each week. Past topics canbe traveled by clicking on the Pathways graphic: Read aboutthe basics of investing; handling portfolio additions andwithdrawals; investing in DRPs; and choosing mutual funds.
Invest Like the ProsLearn methods for prospecting for stocks in our StockScreens section, found under Research in the left-handcolumn on our home page. Each month a different stockscreening method is highlighted. Included are the stockinvesting strategies of pros such as Warren Buffett, PeterLynch, James O’Shaughnessy, and William O’Neil. Also,performance charts show you how each strategy fares overtime.
Keep Current on Additions to our Web SiteWe’ve added a right-hand column to our site where wehighlight new material. Check this area for recent uploads ofAAII publications and special features.
Favorite Member AreasOf course, we continue to offer these valuable sections of our Web site:• AAII Journal archives back to 1991• Past and current Computerized Investing articles• Message boards• A robust download library• Local chapter meeting schedules
Check out our New Web Site Design!We’ve tinkered with our Web site to bring AAII’s wealth of information closer to your fingertips. Along with afreshened-up look, you’ll find your favorite sections and interesting new areas easier to locate.
www.aaii.com
How to Access Members Only AreasWhen prompted for authentication information toenter members only areas of the site, simply typein your AAII member number (from the mailinglabel on your AAII Journal) for both User Nameand Password. Be sure to use your entire eight-digit number, with no extra spaces.
AA
II Jo
urna
l/N
ovem
ber
199
85
MU
TU
AL
FU
ND
S W
OR
KS
HO
P
4A
AII
Jour
nal/
Nov
emb
er 1
998
MU
TU
AL
FU
ND
S W
OR
KS
HO
P
TAB
LE 1
. H
EA
LTH
AN
D T
EC
HN
OLO
GY
SE
CTO
R F
UN
DS
Hea
lth
Sec
tor
Fun
ds
(Tic
ker)
Hea
lth
Sec
tor
Fun
ds
(Tic
ker)
Hea
lth
Sec
tor
Fun
ds
(Tic
ker)
Hea
lth
Sec
tor
Fun
ds
(Tic
ker)
Hea
lth
Sec
tor
Fun
ds
(Tic
ker)
To
p 3
Sec
tors
(P
erce
nta
ge
of
Po
rtfo
lio
)T
op
3 S
ecto
rs (
Per
cen
tag
e o
f P
ort
foli
o)
To
p 3
Sec
tors
(P
erce
nta
ge
of
Po
rtfo
lio
)T
op
3 S
ecto
rs (
Per
cen
tag
e o
f P
ort
foli
o)
To
p 3
Sec
tors
(P
erce
nta
ge
of
Po
rtfo
lio
)T
op
5 S
tock
s (P
erce
nta
ge
of
Po
rtfo
lio
)T
op
5 S
tock
s (P
erce
nta
ge
of
Po
rtfo
lio
)T
op
5 S
tock
s (P
erce
nta
ge
of
Po
rtfo
lio
)T
op
5 S
tock
s (P
erce
nta
ge
of
Po
rtfo
lio
)T
op
5 S
tock
s (P
erce
nta
ge
of
Po
rtfo
lio
)
Fide
lity
Sel
ect
Bio
tech
nolo
gy (
FBIO
X)
biot
ech
43%
, dr
ugs
17%
, ph
arm
ac’l
prep
arat
ions
7%
Gen
ente
ch 1
0.4%
, C
hiro
n 6.
2%,
Gen
zym
e 5.
8%,
6216
21.
493.
00%
fro
nt–1
.011
.510
.616
.7–1
5.4
1.56
Mer
ck 5
.7%
, S
cher
ing-
Plou
gh 4
.4%
T. R
owe
Pric
e H
ealth
Sci
ence
s (P
RH
SX
)ph
arm
ac’ls
25%
, bi
otec
h 21
%,
hosp
ital
supp
ly &
med
dev
ices
16%
Col
lage
n 3.
7%,
IDX
Sys
tem
s 3.
2%,
Pfiz
er 2
.7%
,77
133
1.35
none
0.5
nana
12.5
–15.
4na
War
ner-
Lam
bert
2.7
%,
Nat
iona
l D
ata
2.4%
INV
ESC
O S
trat
egic
Hea
lth S
cien
ces
(FH
LSX
)dr
ugs
57%
, m
edic
al e
quip
18%
, bi
otec
h 5%
Mer
ck 7
.2%
, B
rist
ol-M
yers
Squ
ibb
6.4%
, W
arne
r-La
mbe
rt 6
.4%
,56
143
1.08
none
24.3
22.4
23.3
11.4
–10.
51.
26
Sch
erin
g-Pl
ough
5.6
%,
Am
eric
an H
ome
Prod
ucts
5.3
%
Van
guar
d S
peci
aliz
ed H
ealth
Car
e (V
GH
CX
)dr
ugs
& p
harm
ac’ls
51%
, in
tern
atio
nal
21%
,W
arne
r-La
mbe
rt 5
.9%
, Pf
izer
5.2
%,
Phar
mac
ia &
Upj
ohn
5.1%
,99
100.
401.
00%
19.7
27.0
26.5
10.0
–10.
50.
96 m
edic
al &
den
tal
inst
rum
ents
& s
uppl
ies
8.5%
Bri
stol
-Mye
rs S
quib
b 4.
8%,
Abb
ott
Labo
rato
ries
3.6
%re
dem
ptio
n fe
e
Fide
lity
Sel
ect
Hea
lth C
are
(FS
PHX
)dr
ugs
42%
, m
edic
al s
uppl
ies
& a
pplia
nces
12%
, ho
spita
ls 4
%A
mer
ican
Hom
e Pr
oduc
ts 7
.9%
, W
arne
r-La
mbe
rt 7
.6%
,62
591.
333.
00%
fro
nt29
.327
.129
.711
.6–1
0.4
1.09
Mer
ck 5
.9%
, B
rist
ol-M
yers
Squ
ibb
4.9%
, S
cher
ing-
Plou
gh 4
.9%
Fide
lity
Sel
ect
Med
ical
Del
iver
y (F
SH
CX
)ho
spita
ls 3
5%,
HM
Os
& o
utpa
tient
car
e 24
%,
med
ical
ser
vs 6
%U
nite
d H
ealth
Car
e 8.
2%,
Hea
lth M
anag
emen
t A
ssoc
. 8.
0%,
4910
91.
573.
00%
fro
nt–1
7.0
6.3
14.6
12.0
–22.
61.
61
HEA
LTH
SO
UTH
6.9
%,
Col
umbi
a/H
CA
Hea
lthca
re 5
.7%
, Te
net
Hea
lthca
re 5
.6%
Tec
hn
olo
gy
Sec
tor
Fun
ds
(Tic
ker)
Tec
hn
olo
gy
Sec
tor
Fun
ds
(Tic
ker)
Tec
hn
olo
gy
Sec
tor
Fun
ds
(Tic
ker)
Tec
hn
olo
gy
Sec
tor
Fun
ds
(Tic
ker)
Tec
hn
olo
gy
Sec
tor
Fun
ds
(Tic
ker)
Fide
lity
Sel
ect
Elec
tron
ics
(FS
ELX
)se
mic
ondu
ctor
s 29
%,
com
pute
rs 2
3%,
soft
war
e &
ser
vs 1
3%G
atew
ay 2
000
6.0%
, H
ewle
tt-Pa
ckar
d 5.
9%,
104
435
1.18
3.00
% f
ront
–25.
611
.225
.417
.4–1
9.9
2.27
Mic
roso
ft 4.
5%,
AS
M L
ithog
raph
y 4.
5%,
Texa
s In
stru
men
ts 3
.3%
T. R
owe
Pric
e S
cien
ce &
Tec
hnol
ogy
(PR
SC
X)
sem
icon
duct
or 1
7%,
com
mun
’ns
equi
p 14
%,
softw
are
13%
Para
met
ric T
echn
olog
y 4.
0%,
Ana
log
Dev
ices
3.5
%,
5112
50.
97no
ne–1
5.5
4.4
15.6
14.9
–22.
61.
87 N
etw
ork
Ass
oc.
3.4%
, Fi
rst
Dat
a 3.
3%,
Max
im I
nteg
rate
d Pr
oduc
ts 3
.2%
Fide
lity
Sel
ect
Com
pute
rs (
FDC
PX)
com
pute
rs 4
4%,
sem
icon
duct
ors
16%
, so
ftwar
e &
ser
vs 1
1%D
ell
Com
pute
r 10
.1%
, EM
C 7
.7%
, Q
uant
um 5
.9%
,71
333
1.40
3.00
% f
ront
5.5
17.8
29.7
23.1
–14.
02.
29
Com
paq
Com
pute
r 4.
1%,
Mic
roso
ft 4.
1%
Fide
lity
Sel
ect
Tech
nolo
gy (
FSPT
X)
softw
are
16%
, se
mic
ondu
ctor
s 10
%,
mic
roco
mpu
ters
5%
Mic
roso
ft 9.
7%,
Sel
ectr
on 4
.2%
, D
ell
Com
pute
r 4.
0%,
108
556
1.38
3.00
% f
ront
–4.2
11.9
20.2
17.5
–17.
52.
04
Mic
ron
Tech
nolo
gy 2
.7%
, H
BO
& C
o. 2
.4%
Fide
lity
Sel
ect
Sof
twar
e &
Com
put
Ser
vs (
FSC
SX
)so
ftwar
e 54
%,
com
pute
r se
rvs
10%
, da
ta p
roce
ss’g
6%
Mic
roso
ft 11
.2%
, Pe
ople
Sof
t 7.
5%,
BM
C S
oftw
are
6.8%
,67
145
1.44
3.00
% f
ront
12.0
19.0
20.1
22.1
–18.
31.
96 S
iebe
l S
yste
ms
4.0%
, C
ompu
war
e 3.
3%
Nor
ther
n Te
chno
logy
(N
TCH
X)
softw
are
& s
ervs
36%
, co
mm
un’n
s eq
uip
21%
,C
isco
Sys
tem
s 4.
7%,
Luce
nt T
echn
olog
ies
4.5%
, A
mer
ica
Onl
ine
4.4%
,70
741.
25no
ne5.
8na
na18
.0–2
0.2
na
ele
ctric
al &
ele
ctro
n co
mpo
n 20
% D
ell
Com
pute
r 4.
4%,
Yah
oo 4
.3%
Rob
erts
on S
teph
ens
Info
rmat
ion
Age
(R
SIF
X)
softw
are
& s
ervs
34%
, se
mic
ondu
ctor
s &
com
pon
14%
,Le
gato
Sys
tem
s 4.
3%,
Am
eric
a O
nlin
e 4.
3%,
Net
wor
d A
ssoc
3.7
%,
4636
91.
82no
ne–1
6.0
nana
20.8
–24.
4na
com
mun
’ns
equi
p &
ser
vs 1
0% S
AP
AG
3.7
%,
Vite
sse
Sem
icon
duct
or 3
.2%
INV
ESC
O S
trat
egic
Tec
hnol
ogy
(FTC
HX
)so
ftwar
e &
ser
vs 2
5%,
com
pute
r ha
rdw
are
13%
,IB
M 4
.3%
, Le
xmar
k In
t’l 3
.2%
, In
t’l G
ame
Tech
nolo
gy 3
.2%
,12
023
71.
05no
ne–9
.312
.516
.010
.9–1
7.7
1.52
dat
a pr
oces
s’g
serv
s 10
% C
BT
Gro
up 2
.8%
, C
erid
ian
2.8%
PBH
G T
echn
olog
y &
Com
mun
icat
ions
(PB
TCX
)te
chno
logy
63%
, se
rvic
es 2
4%,
heal
th c
are
2%A
scen
d C
omm
4.8
%,
J.D
. Ed
war
ds 4
.6%
;64
259
1.30
none
–19.
721
.6na
17.3
–16.
62.
04
Citr
ix S
yste
ms
4.0%
, C
ompu
war
e 3.
9% S
avill
e S
yste
ms
3.6%
Fide
lity
Sel
ect
Dev
elop
Com
mun
(FS
DC
X)
tele
phon
e eq
uip
14%
, te
leph
one
serv
s 12
%,
Cel
lsta
r 9.
7%,
Bri
ghtp
oint
7.3
%,
Ani
com
6.8
%,
5538
31.
613.
00%
fro
nt–4
.15.
513
.314
.1–2
0.3
1.96
who
lesa
le e
lect
ric
appl
ianc
es 1
0% A
lcat
el A
lsth
om 5
.5%
, N
okia
4.3
%
Fide
lity
Sel
ect
Tele
com
mun
(FS
TCX
)ph
one
serv
s 47
%,
data
com
mun
equ
ip 6
%,
Wor
ldC
om 8
.6%
, M
CI
Com
mun
7.5
%,
Tel-S
ave
Hol
ding
s 6.
6%,
3115
71.
513.
00%
fro
nt7.
112
.513
.414
.2–2
2.9
1.61
TV
& r
adio
com
mun
equ
ip 5
% A
T&T
5.0%
, G
loba
l Te
lesy
stem
s G
roup
3.6
%
S&
P 5
00 I
nd
exS
&P
500
In
dex
S&
P 5
00 I
nd
exS
&P
500
In
dex
S&
P 5
00 I
nd
ex9
.09
.09
.09
.09
.02
2.5
22
.52
2.5
22
.52
2.5
19
.91
9.9
19
.91
9.9
19
.98
.08
.08
.08
.08
.0–1
4.4
–14
.4–1
4.4
–14
.4–1
4.4
1.1
21
.12
1.1
21
.12
1.1
2
S&
P M
idC
ap 4
00 I
nd
exS
&P
Mid
Cap
400
In
dex
S&
P M
idC
ap 4
00 I
nd
exS
&P
Mid
Cap
400
In
dex
S&
P M
idC
ap 4
00 I
nd
ex–6
.2–6
.2–6
.2–6
.2–6
.21
4.1
14
.11
4.1
14
.11
4.1
13
.61
3.6
13
.61
3.6
13
.69
.99
.99
.99
.99
.91
8.6
18
.61
8.6
18
.61
8.6
1.3
21
.32
1.3
21
.32
1.3
2
Ru
ssel
l 20
00 S
mal
l-C
ap I
nd
exR
uss
ell
2000
Sm
all-
Cap
In
dex
Ru
ssel
l 20
00 S
mal
l-C
ap I
nd
exR
uss
ell
2000
Sm
all-
Cap
In
dex
Ru
ssel
l 20
00 S
mal
l-C
ap I
nd
ex1
9.0
19
.01
9.0
19
.01
9.0
6.8
6.8
6.8
6.8
6.8
9.0
9.0
9.0
9.0
9.0
11
.11
1.1
11
.11
1.1
11
.1–1
9.4
–19
.4–1
9.4
–19
.4–1
9.4
1.4
21
.42
1.4
21
.42
1.4
2S
ourc
e: Q
uart
erly
Low
-Loa
d M
utua
l Fun
d U
pdat
e fo
r st
atis
tics,
with
ret
urns
thro
ugh
Sep
t. 30
, 199
8; p
ortf
olio
info
rmat
ion
supp
lied
by th
e fu
nds.
An
nu
al R
etu
rnA
nn
ual
Ret
urn
An
nu
al R
etu
rnA
nn
ual
Ret
urn
An
nu
al R
etu
rnO
ne-
Mo
nth
Ret
urn
sO
ne-
Mo
nth
Ret
urn
sO
ne-
Mo
nth
Ret
urn
sO
ne-
Mo
nth
Ret
urn
sO
ne-
Mo
nth
Ret
urn
s (
as o
f 9/
30/9
8) (
as o
f 9/
30/9
8) (
as o
f 9/
30/9
8) (
as o
f 9/
30/9
8) (
as o
f 9/
30/9
8)La
st T
hre
e Y
ears
Last
Th
ree
Yea
rsLa
st T
hre
e Y
ears
Last
Th
ree
Yea
rsLa
st T
hre
e Y
ears
To
tal
To
tal
To
tal
To
tal
To
tal
No
. o
fN
o.
of
No
. o
fN
o.
of
No
. o
fP
ort
foli
oP
ort
foli
oP
ort
foli
oP
ort
foli
oP
ort
foli
oE
xpen
seE
xpen
seE
xpen
seE
xpen
seE
xpen
seM
axim
um
Max
imu
mM
axim
um
Max
imu
mM
axim
um
On
e-O
ne-
On
e-O
ne-
On
e-T
hre
e-T
hre
e-T
hre
e-T
hre
e-T
hre
e-Fi
ve-
Five
-Fi
ve-
Five
-Fi
ve-
Hig
h-
Hig
h-
Hig
h-
Hig
h-
Hig
h-
Low
-Lo
w-
Low
-Lo
w-
Low
-R
isk
Ris
kR
isk
Ris
kR
isk
Sto
cks
Sto
cks
Sto
cks
Sto
cks
Sto
cks
Tu
rno
ver
Tu
rno
ver
Tu
rno
ver
Tu
rno
ver
Tu
rno
ver
Rat
ioR
atio
Rat
ioR
atio
Rat
ioLo
adLo
adLo
adLo
adLo
adY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
rY
ea
re
ste
ste
ste
ste
ste
ste
ste
ste
ste
st
Ind
ex
Ind
ex
Ind
ex
Ind
ex
Ind
ex (
%)
(%
) (
%)
(%
) (
%)
(%
) (
%)
(%
) (
%)
(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)(%
)
each
fun
d w
ith
the
perc
ent
of t
hepo
rtfo
lio b
y va
lue
inve
sted
in
each
sect
or.
In t
erm
s of
the
hea
lth
care
spec
trum
, Fi
delit
y Se
lect
Bio
tech
nol-
ogy,
wit
h 43
% i
n bi
otec
h, i
s at
one
end,
and
Fid
elit
y Se
lect
Med
ical
Del
iver
y, w
ith
35%
of
the
port
folio
inve
sted
in
the
hosp
ital
cat
egor
y, i
sat
the
oth
er e
nd.
The
se f
unds
are
liste
d in
rou
gh o
rder
fro
m t
hose
com
mit
ted
sign
ific
antl
y to
bio
tech
,th
roug
h th
ose
that
inc
lude
dru
gs a
nd
phar
mac
euti
cals
, m
edic
al d
evic
esan
d, b
road
er s
till,
med
ical
ser
vice
s.B
ut f
unds
rep
ort
subs
ecti
ons
and
indu
stri
es d
iffe
rent
ly,
so s
ecto
rgr
oupi
ng m
ay b
e so
met
hing
dif
fere
ntfo
r ea
ch f
und.
As
for
indi
vidu
al s
tock
s, M
erck
is
the
mos
t pr
eval
ent
in t
he t
op f
ive
hold
ings
, bu
t al
l th
e m
ajor
dru
g/ph
arm
aceu
tica
ls m
aker
s ar
e th
ere:
War
ner-
Lam
bert
, B
rist
ol-M
yers
Squi
bb,
Sche
ring
-Plo
ugh,
Pfi
zer,
Phar
mac
ia &
Upj
ohn,
and
Am
eric
aH
ome
Prod
ucts
. Fi
delit
y Se
lect
Bio
tech
nolo
gy a
nd T
.Row
e Pr
ice
Hea
lth
Scie
nces
ten
d to
hol
d m
ore
biot
ech
drug
com
pani
es—
high
er r
isk,
high
er r
etur
n, d
rug
deve
lopm
ent
stoc
ks.
How
div
ersi
fied
are
the
se s
ecto
rfu
nds?
A d
iver
sifi
ed s
ecto
r fu
nd i
ssu
rely
an
oxym
oron
, bu
t th
e un
der-
lyin
g qu
esti
on i
s: h
ow c
once
ntra
ted
is t
he p
ortf
olio
? Fi
delit
y Se
lect